STRUCTURE THERAPEUTICS INC (GPCR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$47.340.00%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GPCR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||
| R&D Expenses | 294.2 | 225.3 | 108.8 | 70.1 | 36.2 | — |
| Operating Income | (257.8) | (176.6) | (158.2) | (102.8) | (52.6) | — |
| Earnings from Continuing Operations | ||||||
| EBT, Incl. Unusual Items | (214.1) | (140.7) | (122.2) | (89.4) | (51.3) | — |
| Income Tax Expense | 0.7 | 0.5 | 0.3 | 0.2 | 0.0 | — |
| Net Income | ||||||
| Net Income | (214.8) | (141.2) | (122.5) | (89.6) | (51.3) | — |
| Per Share | ||||||
| Basic EPS | (0.99) | (0.80) | (0.78) | (0.81) | (5.51) | — |
| Diluted EPS | (0.99) | (0.80) | (0.78) | (0.81) | (5.51) | — |
| Basic Weighted Avg Shares | 218.0 | 177.6 | 157.9 | 110.2 | 9.6 | — |
| Diluted Weighted Avg Shares | 218.0 | 177.6 | 157.9 | 110.2 | 9.6 | — |
| Supplemental | ||||||
| EBIT | (257.8) | (176.6) | (158.2) | (102.8) | (52.6) | — |
| Effective Tax Rate | -0.3% | — | — | -0.3% | -0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.